Pharmafile Logo
Pharmafocus logo
Advanced Search

Anup Shah joins Woolley Pau PR

June 25, 2010
Medical Communications Woolley Pau, appointment, medical communications

Anup Shah has joined Woolley Pau PR as account director to develop the UK agency’s PR’s medical communication team. He …

Appointment

Sanofi licences novel oral anti-diabetic treatment

June 25, 2010
Research and Development, Sales and Marketing Metabolex, Sanofi-Aventis, diabetes

Sanofi-Aventis has signed an exclusive worldwide licensing agreement with US-based diabetes specialist Metabolex for a novel oral anti-diabetic treatment. MBX-2982 …

News

NICE re-thinks arthritis guidance

June 25, 2010
Sales and Marketing Enbrel, Humira, MabThera, NICE, Orencia, Remicade, TNF, rheumatoid arthritis

NICE has approved five rheumatoid arthritis treatments in certain circumstances after treatment with a tumour necrosis factor inhibitor has failed. …

News
Pfizer iPad app

Digital Pharma: First pharma iPad apps

June 25, 2010
Medical Communications, Sales and Marketing Apple, Pfizer, Sanofi, app, ipad, iphone

The first big pharma apps specially designed for Apple’s iPad have started to emerge, with Pfizer and Sanofi leading the …

News

WPP forms largest healthcare coms network

June 25, 2010
Medical Communications CommonHealth, Ogilvy, WPP, ogilvy healthworld advertising

Global communications giant WPP has merged its Ogilvy Healthworld and CommonHealth businesses. Named Ogilvy CommonHealth Worldwide, the new entity becomes …

News

Merck moves tropical disease drug into phase II

June 25, 2010
Research and Development Chagas disease, Merck & Co, Noxafil, tropical disease

Merck & Co is to see whether its oral antifungal agent Noxafil (posaconazole) can be used in chronic cases of …

News

Clavis Pharma appoints Athos Gianella-Borradori

June 24, 2010
Research and Development Clavis Pharma, appointment, research and development

Athos Gianella-Borradori has joined clinical stage oncology drug development company Clavis Pharma as chief medical officer. His appointment to the …

Appointment

NICE rejects Glivec as adjuvant therapy

June 24, 2010
Sales and Marketing Glivec, NICE, Novartis

NICE has rejected the use of Novartis’ Glivec as an adjuvant treatment for people who have had a gastrointestinal stromal …

News

AstraZeneca and Targacept begin depression trials

June 24, 2010
Research and Development AstraZeneca, Targacept, depression

AstraZeneca and Targacept have begun enrolling patients in phase III trials for TC-5214, a new treatment for depression. The new …

News

CME Spotlight: Coalition politics in European CME

June 24, 2010
Medical Communications CME, CME Spotlight

The election is now over and rather than the damp squib that I foresaw, it feels like something new and …

Feature

Prix Galien shortlist unveiled

June 24, 2010
Research and Development prix galien

The shortlist of innovative medicines which will compete for two prestigious UK Prix Galien medals later this year has been …

News

Pfizer plant cleared by FDA to make NicOx drug

June 24, 2010
Manufacturing and Production Capsugel, NicOx, Pfizer, manufacturing, naproxcinod

Pfizer subsidiary Capsugel has won approval from the US Food and Drug Administration for a manufacturing facility based in France …

News
Blog footer

Digital Pharma: Playing healthcare games

June 23, 2010
Medical Communications Boehringer, Novartis, diabetes, digi game, malaria, virtual games

Boehringer Ingelheim has become the latest pharma company to use an online game to raise disease awareness. The pharma company …

News
UKCRMI

Plans for UK’s research hub unveiled

June 23, 2010
Research and Development Cancer Research UK, MRC, UCL, UKCMRI, Wellcome, biomedical

The vision for a new UK biomedical research and innovation centre which will be the biggest in Europe has been …

News

Prosensa and GSK add to muscular dystrophy alliance

June 23, 2010
Research and Development GlaxoSmithKline, Prosensa, muscular dystrophy

GSK has extended its research alliance with biotech company Prosensa in the field of muscular dystrophy. Netherlands-based Prosensa focuses on …

News
George Osborne

Mixed reaction for Osborne’s first Budget

June 23, 2010
Research and Development, Sales and Marketing biotech, pharma, tax, tax relief

George Osborne’s first Budget as chancellor has had a mixed reception from the pharma and biotech sectors. The BioIndustry Association …

News

Congress summons J&J chief executive

June 23, 2010
Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance

The Congressional committee looking into the recalls ordered by Johnson & Johnson unit McNeil Consumer Healthcare is planning to hold …

News

PRA bolsters late phase services

June 23, 2010
Research and Development CRO, PRA, appointment, research and development

Contract research organisation PRA International has appointed Hani Zaki senior VP of its Late Phase Services business. Late Phase Services …

Appointment

Sanofi signs microRNA therapy deal

June 23, 2010
Research and Development RNA, Regulus, Sanofi-Aventis

Sanofi-Aventis has entered into a global strategic alliance with US-based therapeutics firm Regulus to develop and commercialise microRNA therapeutics. Regulus …

News

Medical Affairs at the Centre of Life Sciences Innovation

June 22, 2010
Research and Development Kinapse, Medical Affairs, Real World Development, consulting, outsourcinf

In today’s challenging business environment, many innovative life sciences companies are raising questions about the return on investment of internal …

Feature
Thought Leadership
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025